PFA
LH icon

Pathway Financial Advisers’s Labcorp LH Stock Holding History

Pathway Financial Advisers’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-139
Closed -$39.7K – 262
2025
Q3 		$39.7K Buy
+139
New +$37.2K 0.01% 252
2025
Q1 		– Sell
-138
Closed -$31.4K – 303
2024
Q4 		$31.4K Buy
138
+1
+0.7% +$229 0.01% 269
2024
Q3 		$30.5K Hold
137
– – 0.01% 221
2024
Q2 		$27.7K Buy
137
+2
+1% +$407 0.01% 268
2024
Q1 		$29.6K Hold
135
– – 0.01% 268
2023
Q4 		$30.7K Hold
135
– – 0.01% 263
2023
Q3 		$27.1K Buy
+135
New +$28.5K 0.01% 268
2023
Q1 		$30.7K Sell
156
-47
-23% -$9.67K 0.01% 264
2022
Q4 		$41.1K Buy
+203
New +$39.7K 0.02% 258

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pathway Financial Advisers's LH Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Labcorp (LH) in Q4 2025, closing a stake of 139 shares — an estimated $39.7K sold.

Pathway Financial Advisers first reported a position in LH in Q4 2022 and held it in 9 quarters. The position peaked at $41.1K in Q4 2022. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 139 Labcorp shares in Q4 2025, an estimated $39.7K.
  • Pathway Financial Advisers first reported a position in Labcorp in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's Labcorp position peaked at $41.1K in Q4 2022.
  • 1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.